Brain Nerve. 2012 Jun;64(6):681-7.

[Frequency of the Use of Vagus Nerve Stimulation for the Treatment of Intractable Epilepsy during the First Year of Public Health Insurance Coverage with in Kyushu Rosai Hospital and Other Areas in Japan].

[Article in Japanese]

Morioka T, Sayama T, Shimogawa T, Hamamura T, Hashiguchi K, Kawai K, Mukae N, Murakami N, Sasaki T.

Source

Department of Neurosurgery, Kyushu Rosai Hospital.

Abstract

Abstract Vagus nerve stimulation (VNS) is a palliative treatment for medically intractable epilepsy and has been covered by public health insurance in Japan since July 1, 2010. The frequency of the use of VNS during the first year of insurance coverage was determined by assessing the number of cases for which VNS was performed in Kyushu Rosai Hospital, the number of registered cases, and the questionnaire survey filled by 68 surgeons who are board certified as both epileptologists and neurosurgeons. VNS devices were placed in 98 patients from July 2010 to June 2011. These devices were placed in an average of 4.4 patients per month from July 2010 to November 2010 and in an average of 10.9 patients from December 2010 to June 2011. However, we did not observe an increasing trend. Almost all of the surgeries were performed in the Kanto (56 patients in 8 institutes) and Tokai (24 patients in 2 institutes) areas. VNS was not performed in many institutes primarily because VNS was not indicated for any of the patients. The questionnaire survey indicated that the use of VNS was likely to increase with an increase in the number of neurologists who decide on performing VNS preoperatively and regulate the conditions of the vagus nerve stimulator postoperatively. In conclusion, VNS is currently being applied in a limited number of institutes in the Kanto and Tokai areas, and a close association between the epileptologists and neurologists during preoperative and postoperative periods will increase the use of VNS. (Received: August 17, 2011, Accepted: December 19, 2011).

PMID:

22647476

[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/22647476

Related citations in PubMed

• Vagus nerve stimulation after lead revision.[Neurosurg Focus. 2012]
  Vagus nerve stimulation after lead revision.

  Dlouhy BJ, Viljoen SV, Kung DK, Vogel TW, Granner MA, Howard MA 3rd, Kawasaki H. Neurosurg Focus. 2012 Mar; 32(3):E11.
• Cumulative effect of vagus nerve stimulators on intractable seizures observed over a period of 3years.[Epilepsy Behav. 2010]
  Cumulative effect of vagus nerve stimulators on intractable seizures observed over a period of 3years.

  Siddiqui F, Herial NA, Ali II. Epilepsy Behav. 2010 Jul; 18(3):299-302. Epub 2010 May 23.
• Vagus nerve stimulation for the treatment of medically intractable seizures. Results of a 1-year open-extension trial. Vagus Nerve Stimulation Study Group.[Arch Neurol. 1996]
  Vagus nerve stimulation for the treatment of medically intractable seizures. Results of a 1-year open-extension trial. Vagus Nerve Stimulation Study Group.

  Salinsky MC, Uthman BM, Ristanovic RK, Wernicke JF, Tarver WB. Arch Neurol. 1996 Nov; 53(11):1176-80.
• Review Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response.[J Neurosurg. 2011]
  Review Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response.

  Englot DJ, Chang EF, Auguste KI. J Neurosurg. 2011 Dec; 115(6):1248-55. Epub 2011 Aug 12.
• Review Vagus nerve stimulation for seizures.[Arch Med Res. 2000]